Form 8-K Science Applications For: Dec 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- Wall St slips as Gulf tensions send oil to over six-week high
- European shares subdued as surging crude sharpens focus on ECB rate path
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Goldman Sachs on Science Applications (SAIC): 'soft bookings; tightened EBITDA guidance'
December 5, 2024 7:51 AM ESTGoldman Sachs analyst Gavin Parsons reiterated a Sell rating and $124.00 price target on Science Applications (NASDAQ: SAIC)
The analyst comments "ottom line: SAIC reported F3Q25 revenue, adjusted EBITDA margin, and EPS ahead of Factset consensus, though FCF below. Revenue was up 4% yoy on an organic basis. Adjusted EBITDA margin of 10.0% is up 60bps yoy and 50bps ahead of our expectation,... More
